A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding

Clinical trial NCT05841394 · COMPLETED

Trial details

NCT number: NCT05841394
Sponsor: Livzon Pharmaceutical Group Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stress Ulcer Bleeding

Start date: 2021-07-16
Primary completion: 2022-04-28
Enrollment: 449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.